WILMINGTON, Del. - Bankrupt Savient Pharmaceuticals Inc. on Feb. 10 filed a plan of liquidation in the U.S. Bankruptcy Court for the District of Delaware under which holders of allowed administrative expense claims, secured claims and tax claims would receive full satisfaction of their claims (In Re: Savient Pharmaceuticals Inc., No. 13-12680, Chapter 11, D. Del. Bkcy.).